Inhaled corticosteroids (ICS) are important in reducing exacerbation frequency associated
with chronic obstructive pulmonary disease (COPD). However, little is known about the risk …

BACKGROUND Early treatment with inhaled corticosteroids appears to improve clinical
symptoms in asthma. Whether a first treatment initiated in the year following the recognition …

Objective To address clinical concern regarding the use of inhaled corticosteroids (ICSs)
and the risk for pneumonia, particularly among patients with chronic obstructive pulmonary …

Can inhaled corticosteroids influence the natural history of... : Current Opinion in Allergy and
Clinical Immunology Can inhaled corticosteroids influence the natural history of asthma …

Background Low inhaled corticosteroid (ICS) adherence is associated with increased
asthma burden. This relationship is likely bidirectional, and may vary across adherence …

Background Although systemic corticosteroid (SCS) treatment, irrespective of duration or
dosage, is associated with adverse outcomes for patients with asthma, the longitudinal …

Background Chronic oral corticosteroid (C-OCS) use in asthma is an indicator of disease
severity, but its risk factors are largely unknown. Objective To describe patient characteristics …

BACKGROUND: Oropharyngeal adverse events associated with inhaled corticosteroid (ICS)
use can affect adherence; however, these effects have been studied less extensively than …

BACKGROUND: Few studies have investigated the long-term association between inhaled
corticosteroids (ICSs) and lung function decline in asthma. OBJECTIVE: To evaluate …

BACKGROUND: Although guidelines recommend anti-inflammatory therapy for persistent
asthma, recent studies suggest that 25% to 35% of patients with asthma may not improve …